It may boost energy levels as it increases the amount of fuel availability that the heart requires to function
In contrast, BRP has not demonstrated any noticeable adverse effects in animal models, suggesting a potentially superior safety profile
We believe these data underscore the potential of CagriSema to address unmet medical needs in obesity and support long-term disease management." The NDA is based on results from REDEFINE 1, a 68-week, phase 3, randomized, double-blind, placebo-and active-controlled trial that evaluated the efficacy and safety of once-weekly CagriSema compared to semaglutide 2.4 mg alone, cagrilintide 2.4 mg alone, or placebo, all as an adjunct to lifestyle intervention in 3,417 adults with obesity (BMI 30 kg/m 2 ) or overweight (BMI 27 kg/m 2 ) with one or more obesity-related complications and without diabetes, and REDEFINE 2, a double-blind, randomized, placebo-controlled, 68-week, phase 3 trial that evaluated the efficacy and safety of once-weekly CagriSema versus placebo, as an adjunct to lifestyle intervention in 1,206 adults with type 2 diabetes and either obesity (BMI 30 kg/m 2 ) or overweight (BMI 27 kg/m 2 )
The result is a flatter lower stomach and a smoother scar line
Other symptoms include: bloating and belching nausea vomiting reduced appetite and weight loss These ulcers Diverticula Diverticula are small pockets that can form inside the colon
13 If your marketing materials mention price savings, you are handing the manufacturer evidence for their next lawsuit
